4//SEC Filing
Albanna Rowena 4
Accession 0001213900-21-012345
CIK 0001726711other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 6:14 AM ET
Size
5.0 KB
Accession
0001213900-21-012345
Insider Transaction Report
Form 4
Albanna Rowena
CHIEF OPERATING OFFICER
Transactions
- Award
Common Stock
2021-02-24+225,000→ 772,220 total(indirect: See Footnote)
Footnotes (2)
- [F1]The restricted common stock shall vest in three (3) successive equal annual installments, beginning on March 31, 2021.
- [F2]Held beneficially by the husband of the Reporting Person.
Documents
Issuer
Aditx Therapeutics, Inc.
CIK 0001726711
Entity typeother
Related Parties
1- filerCIK 0001818598
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 6:14 AM ET
- Size
- 5.0 KB